Navigation Links
Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013

Boston, Ma (PRWEB) June 13, 2013

Cambridge Semantics will be a featured presenter at DIA 2013 taking place June 23rd through the 27th in Boston. As part of the Innovation Theater track, Cambridge Semantics will showcase how technology innovations made possible by semantics can help pharmaceutical companies improve drug safety and bolster business development while minimizing risk.

The most important data-related challenge facing pharma today is the ability to use data to make critical business decisions. Most of these decisions don’t need Big Data: they simply need the right data at the right time. Semantic Web standards enable pharmaceutical organizations to make data smarter by offering greater data access and data understanding, allowing them to more effectively mitigate risk across the drug development and commercialization spectrum.

Session information
Tuesday, June 25th at Noon EDT
Title: “How Can Technology Change the Way Pharmas Handle Risk? Innovations in Drug Safety and Business Development
Location: Exhibit Hall

Based on Semantic Web technologies, the award-winning Anzo Pharma Competitive Intelligence Solution from Cambridge Semantics is currently in use at some of the world’s top biopharma organizations. R&D teams, business development, marketing and knowledge management groups leverage Anzo to easily route targeted information to the right people at the right time from the right sources, incorporating both structured and unstructured data. As a result, pharmaceutical organizations can harmonize information more rapidly and make better business decisions.

To learn more about Cambridge Semantics and the award winning Anzo Pharma Competitive Intelligence Solution please visit

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit or follow us on Twitter @CamSemantics.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
2. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
5. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
6. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
7. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
10. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
11. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... 2015  Clintrax Global, Inc., a worldwide provider of clinical research ... announced that the company has set a new quarterly earnings record ... quarter growth posted for Q3 of 2014 to Q3 of 2015. ... Mexico , with the establishment of an Asia-Pacific ... United Kingdom and Mexico ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):